Max-Felix Häring - JoVE Visualize

Showing results (1-10 of 5) with videos related to

Pageof 1

Sort By:

Deutsche Medizinische Wochenschrift (1946)|October 4, 2022

[Chemotherapy of malignant tumors]Max-Felix Häring, Claudia Lengerke

Thoracic Cancer|May 7, 2020

Life-threatening pneumonitis after first-line treatment with osimertinib for primary T790M mutated non-small cell lung cancerMaik Häntschel, Johannes Niebling, Almut Häring, et al.

Frontiers in Oncology|September 1, 2023

Case Report: Paraneoplastic psoriasis in thymic carcinomaLucas Mix, Manuel Knoll, Max-Felix Häring, et al.

Nature Medicine|May 31, 2026

MAGE-A4/MAGE-A8-targeted TCR-based bispecific T cell engager in recurrent and/or refractory solid tumors: a phase 1 trialMartin Wermke, Sebastian Ochsenreither, Dirk Jaeger, et al.

Blood Cancer Discovery|October 17, 2023

Immune Surveillance of Acute Myeloid Leukemia Is Mediated by HLA-Presented Antigens on Leukemia Progenitor CellsAnnika Nelde, Heiko Schuster, Jonas S Heitmann, et al.

Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:

Pageof 1

Deutsche Medizinische Wochenschrift (1946)|October 4, 2022

[Chemotherapy of malignant tumors]Max-Felix Häring, Claudia Lengerke

Thoracic Cancer|May 7, 2020

Life-threatening pneumonitis after first-line treatment with osimertinib for primary T790M mutated non-small cell lung cancerMaik Häntschel, Johannes Niebling, Almut Häring, et al.

Frontiers in Oncology|September 1, 2023

Case Report: Paraneoplastic psoriasis in thymic carcinomaLucas Mix, Manuel Knoll, Max-Felix Häring, et al.

Nature Medicine|May 31, 2026

MAGE-A4/MAGE-A8-targeted TCR-based bispecific T cell engager in recurrent and/or refractory solid tumors: a phase 1 trialMartin Wermke, Sebastian Ochsenreither, Dirk Jaeger, et al.

Blood Cancer Discovery|October 17, 2023

Immune Surveillance of Acute Myeloid Leukemia Is Mediated by HLA-Presented Antigens on Leukemia Progenitor CellsAnnika Nelde, Heiko Schuster, Jonas S Heitmann, et al.

Pageof 1